InvestorsHub Logo
Followers 53
Posts 1783
Boards Moderated 0
Alias Born 03/22/2015

Re: Rolling inflaton post# 203709

Wednesday, 06/08/2016 12:58:58 PM

Wednesday, June 08, 2016 12:58:58 PM

Post# of 403187
This must be what Pfizer is talking about?


http://blogs.fda.gov/fdavoice/index.php/2016/02/changing-course-a-new-approach-to-opioid-pain-medication-at-fda/



Changing course: A new approach to opioid pain medication at FDA

Posted on February 5, 2016 by FDA Voice


By: Robert M. Califf, M.D.





First, we’re going to be more transparent and open in the approval process for this category of drugs. Starting today, the FDA will convene an expert advisory committee before approving any new drug application for an opioid that is not in an abuse-deterrent formulation (ADF).





Robert M. Califf, M.D., previously FDA’s Deputy Commissioner for Medical Products and Tobacco, became FDA’s Commissioner of Food and Drugs on Feb. 25, 2016





"There are three kinds of lies: lies, damned lies, and statistics."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News